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ABSTRACT
Staphylococcus aureus is the leading cause of infective endocarditis (IE). While the role of S. aureus
cell-wall associated protein clumping factor A (ClfA) in promoting IE has been already demon-
strated, that of the secreted plasma-clotting factors staphylocoagulase (Coa) and von Willebrand
factor-binding protein (vWbp) has not yet been elucidated. We investigated the role of Coa and
vWbp in IE initiation in rats with catheter-induced aortic vegetations, using Lactococcus lactis
expressing coa, vWbp, clfA or vWbp/clfA, and S. aureus Newman Δcoa, ΔvWbp, ΔclfA or Δcoa/
ΔvWbp/ΔclfA mutants. vWbp-expression increased L. lactis valve infection compared to parent and
coa-expressing strains (incidence: 62%, versus 0% and 13%, respectively; P < 0.01). Likewise,
expression of clfA increased L. lactis infectivity (incidence: 80%), which was not further affected
by co-expression of vWbp. In symmetry, deletion of the coa or vWbp genes in S. aureus did not
decrease infectivity (incidence: 68 and 64%, respectively) whereas deletion of clfA did decrease
valve infection (incidence: 45%; P = 0.03 versus parent), which was not further affected by the
triple deletion Δcoa/ΔvWbp/ΔclfA (incidence: 36%; P > 0.05 versus ΔclfA mutant). Coa does not
support the initial colonization of IE (in L. lactis) without other key virulence factors and vWbp
contributes to initiation of IE (in L. lactis) but is marginal in the present of ClfA.
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Introduction
Staphylococcus aureus is the most common etiological
agent of infective endocarditis (IE) owing to its propensity
to adhere to fibrin-platelet clots on damaged cardiac valves,
known as vegetations [1,2]. Several structures in the S.
aureus envelope, including teichoic acids and surface-asso-
ciated proteins, have been implicated in ligand-receptor
interactions of circulating bacteria to cardiac vegetations
and contributed to the pathogenesis of IE [3–5].
The study of gene inactivation in S. aureus has greatly
contributed to elucidate the specific role of individual
virulence factors in the pathogenesis of IE [6]. This has
beenmore recently complemented by the use of the poorly
pathogenic Lactococcus lactis, used as a surrogate carrier, to
investigate the effects of heterologous gene expression on
infectivity [7]. Using these methods cooperatively, it was
shown that fibrinogen-binding protein clumping factor A
(ClfA) and fibronectin-binding protein A (FnBPA, which
also binds fibrinogen) were major determinants of S.
aureus valve colonization [4,6,8–10]. For instance, while
S. aureusmutants defective in clfA became less pathogenic,
non-virulent L. lactis expressing recombinant clfA demon-
strated increased infectivity in rats with experimental IE,
due, amongst others, to the acquisition of the ability to
adhere to fibrin deposited on damaged valve tissues [6,7].
In addition to cell-wall anchored adhesins, S. aureus
also produces two procoagulant factors, namely staphy-
locoagulase (Coa) [11] and von Willebrand factor-bind-
ing protein (vWbp) [12], that can activate prothrombin in
a non-proteolytic manner [13]. These proteins trigger the
polymerization of fibrinogen into fibrin and promote
platelet aggregation and blood clotting [13–15].
Contemporary studies showed that Coa and vWbp
might contribute to the pathogenesis of S. aureus in
murine and rabbit models of abscess formation, blood
stream infection and endovascular colonization [16–19].
Nevertheless, their role in the pathogenesis of S. aureus IE
remains unclear. On the one hand, two pioneer studies
performed in rats with catheter-induced aortic
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vegetations reported that Coa was not involved in the
early colonization of damaged valves [6,20] but, since at
the time the presence of vWbp was still unknown [12], the
lack of Coa activity in coa-defective mutants might have
been compensated for by that of vWbp. Moreover, one
study using heterologous expression of coa in
Streptococcus gordonii suggested that Coa did not contri-
bute to infectivity, further supporting the notion that Coa
was not implicated in the initiation of IE [21].
On the other hand, taking the two procoagulant
factors into account, Panizzi and co-workers demon-
strated that knocking out both of them in S. aureus
significantly increased mice survival in a model of S.
aureus IE [22]. However, this study did not investigate
the ability of the bacteria to initiate IE.
The aim of the present work was to provide new
insights into the specific roles of Coa and vWbp in the
initiation of experimental IE due to S. aureus in the rat
model of catheter-induced aortic vegetations. To this
end we used a series of knock-in and knock-out
mutants including (i) L. lactis heterologously expressing
S. aureus coa, vWbp, coa plus vWbp, clfA, and vWbp
plus clfA, and (ii) S. aureus Newman mutants inacti-
vated in the coa, vWbp, clfA, and coa/vWbp/clfA genes.
Results
Recombinant L. lactis strains produce functional
Coa and vWbp
In order to verify that the recombinant L. lactis strains
produced functional procoagulant S. aureus Coa and
vWbp proteins, we assessed both their abilities to induce
blood clotting and to trigger platelet aggregation.
As shown in Figure 1(a), all L. lactis strains expressing
the S. aureus pro-coagulant factors, but not the parent L.
lactis pIL253 strain, exhibited blood clotting activity.
Consistently, dabigatran prevented blood clot formation
by recombinant L. lactis strains (Figure 1(b)).Moreover, it
took 100-times less lactococci producing Coa than vWbp
to trigger coagulation within 24 h (Figure 1(c)).
Since both S. aureus Coa and vWbp are able to induce
platelet aggregation [13,23], the capacity of Coa and vWbp
L. lactis recombinants to trigger platelet aggregation was
also tested. Moreover, since a previous study by McDevitt
and collaborators showed that a fraction of Coa was
retained on the surface of S. aureus [24], the ability of the
L. lactis Coa and L. lactis vWbp cell-free supernatants and
cells to induce platelet aggregation was also tested to verify
whether Coa and vWbp were also partially associated to
the surface of lactococci. As shown in Figure 1(d), platelet
aggregation was observed upon addition of the cell-free
supernatants of L. lactis expressing coa and vWbp, but not
upon the addition of the supernatants of the parent L. lactis
pIL253. When cells were used, only Coa-positive lactococ-
cal cells exhibited platelet aggregation activity (Figure 1(e)).
Collectively, these results indicate that the recombi-
nant L. lactis strains produced and secreted functional
S. aureus Coa and vWbp and that part of Coa, but not
vWbp, was attached to the surface of L. lactis.
Expression of vWbp but not Coa supports L. lactis
infection of aortic vegetations in rats
To study the effect of coa and vWbp expression on
lactococcal infectivity, we titrated the ability of parent
L. lactis pIL253 and recombinant L. lactis Coa, L. lactis
vWbp and L. lactis Coa/vWbp to induce experimental
IE in rats. As shown in Figure 2, 24 h after challenge, in
animals inoculated with 106 CFU, the percentage of
vegetations infected with L. lactis vWbp was signifi-
cantly higher (62%) than that infected with the parent
L. lactis pIL253 (0%; P < 0.01) and L. lactis Coa (13%;
P = 0.007). Not indicated in the Figure, the percentage
of vegetations infected with L. lactis expressing both coa
and vWbp was similar (62%) to that of L. lactis vWbp.
When animals were inoculated with 10-times more
bacterial cells (107 CFU), L. lactis Coa remained sur-
prisingly poorly infective (33% of endocarditis), while
L. lactis pIL253 and L. lactis vWbp were able to infect
≥ 90 % of vegetations.
Of note, the mean bacterial densities ± standard
deviation (SD) in the animals that developed endocar-
ditis (3.58 ± 0.71 log10 CFU/g) in animals challenged
with L. lactis Coa were significantly lower (P < 0.001;
one-way ANOVA) from that of L. lactis pIL253
(5.45 ± 0.78 log10 CFU/g) and L. lactis vWbp
(7.70 ± 0.40 log10 CFU/g). At higher bacterial inocula
(108 CFU) all L. lactis strains were able to infect ≥ 80%
of vegetations. In animals that developed endocarditis,
the mean bacterial densities in the vegetations with L.
lactis Coa (5.92 ± 0.67 log10 CFU/g) were similar to that
with L. lactis pIL253 (5.46 ± 0.82 log10 CFU/g) but
significantly lower (P < 0.01; one-way ANOVA) to
that with L. lactis vWbp (7.75 ± 0.44 log10 CFU/g).
In sum, these results showed that vWbp but not Coa
increased the infectivity of L. lactis, supporting a role of
vWbp in the initiation of IE. On the contrary, Coa
production paradoxically decreased the ability of lacto-
cocci to colonize aortic vegetations.
Coa promotes the clearance of L. lactis from the
vegetations
Previous work by Bayer et al. [25] showed that the
hyperproduction of alpha-toxin by S. aureus resulted
1616 S. MANCINI ET AL.
in a paradoxically reduced virulence in experimental
endocarditis. Moreover, they demonstrated that the
reduced in vivo virulence of the alpha-toxin-producer
variant was not due to differences in initial adherence
to sterile vegetations compared to the parental strain,
and suggested a role of platelet-induced bacterial kill-
ing in the vegetations [25]. We investigated whether
the same scenario could apply to the lower infectivity
rate observed with L. lactis Coa in animals challenged
with the 107 CFU inoculum. Thus, in a second set of
Figure 1. Functional analysis of recombinant L. lactis Coa and L. lactis vWbp. The activity of Coa and vWbp was evaluated by blood
clotting, time required to induce plasma clotting and platelet aggregation. For blood clotting, citrated rat blood without (a) and with
(b) dabigatran was infected with 107 CFU of either parent L. lactis pIL253, L. lactis Coa, L. lactis vWbp or L. lactis Coa/vWbp cells from
an overnight culture and incubated 24 h at 37°C. Tubes were tilted to display blood coagulation. Data are representative of three
independent experiments. To assess the time required to induce plasma clotting (c), 105 to 108 CFU of parent L. lactis pIL253,
recombinant L. lactis Coa or L. lactis vWbp were incubated at 37°C with rat plasma. Tubes were tilted to assess plasma coagulation at
4, 8, 12, 24 and 36 h. Clotting values of 36 h, the maximal time of measurement, indicate that there was no clotting. Data are
representative of three independent experiments. For platelet aggregation, cell-free supernatants (d) or pelleted cells (e) of parent L.
lactis pIL253, or recombinant L. lactis Coa or L. lactis vWbp from overnight cultures were mixed with platelet rich plasma. Platelet
aggregation was monitored by aggregometry and the maximum values of light transmission (maximal aggregation) reached over
20 min incubation were recorded. Data are expressed as mean ± standard deviation (SD) of three independent assays.
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experiments we followed disease progression by
infecting rats with 107 CFU of each lactococcal
recombinant, and assessed the evolution of valve
infection in groups of 6–10 rats sequentially sacri-
ficed over a period of 24 h. As shown in Figure 3(a),
2 h after bacterial challenge all the rats were infected
and had similar vegetation bacterial titers irrespective
of the infecting organism, indicating that all the
lactococcal recombinants were comparably able to
colonize the vegetations. However, the disease
evolved differently later on. While the vegetation
density of parent L. lactis pIL253 remained stable
over time, the vegetation density of L. lactis vWbp
recombinants increased whereas the vegetation den-
sity of Coa-positive lactococci decreased until eradi-
cation at 24 h. These results are in line with those
obtained in rats infected with 107 CFU and killed at
24 h post-challenge, where most of the vegetations
were sterile (see Figure 2). Thus, Coa production by
lactococci attached to the vegetations promoted
active bacterial clearance from the fibrin-platelet
clots.
To support the hypothesis of the platelet-mediated
clearance of L. lactis Coa in the vegetations, freshly-
prepared platelet-rich plasma (PRP) from rats was
incubated with lactococcal cells and the number of
viable cells was assessed after 4 and 24 h of incubation
at 37°C. As shown in Figure 3(b), while viability of L.
lactis piL253 and L. lactis vWbp did not change over
time, numbers of L. lactis Coa were significantly
reduced after 24 h incubation, supporting the notion
that Coa triggers platelet-induced bacterial killing in
the in the platelet-fibrin network.
vWbp does not increase L. lactis IE in the presence
of ClfA
Previous studies using recombinant L. lactis expressing
ClfA or ClfA-defective S. aureus have demonstrated that
ClfA plays a pivotal role in the initiation of experimental IE
[6,7]. To further investigate the role of vWbp in the pre-
sence of ClfA, we generated a double vWbp/clfA recombi-
nant L. lactis by inserting vWbp in L. lactis ClfA [6] and
assessed its ability to induce IE. As shown in Figure 4,
when rats were challenged with inocula containing 104
CFU, L. lactis ClfA exhibited a poor valve infection rate,
but co-expression of vWbp did not increase L. lactis valve
infection. At higher inoculum (105 CFU), L. lactis expres-
sing clfA and L. lactis expressing both clfA and vWbp were
more prone to induce experimental IE than L. lactis
expressing vWbp alone (P = 0.19 and P = 0.08, respectively;
Chi-squared test). However, due to the high infectivity of
L. lactis ClfA (> 80% of vegetations), it was impossible to
investigate whether the concomitant production of vWBP
had a cooperative effect on promoting IE initiation.
All animals that developed endocarditis when inocu-
lated with 105 CFU/ml had similar vegetation bacterial
densities, i.e. 5.73 ± 0.97 log10 CFU/g (L. lactis pIL253),
6.00 ± 1.05 log10 CFU/g (L. lactis Coa) and 5.59 ± 0.46
log10 CFU/g (L. lactis vWbp); (P > 0.05; one-way
ANOVA).
Figure 2. vWbp but not coa confers L. lactis the ability to infect pre-existing sterile valve vegetations. Infectivity titration of the L.
lactis test organisms in the rat model of experimental endocarditis. The rats were challenged with bacterial inocula of gradually
increasing sizes. The columns indicate the percentage of positive vegetations 24 h after bacterial challenge. The number of infected/
total number of animals per group is indicated at the top of the columns. *, P < 0.05 compared with L. lactis Coa; #, P < 0.05
compared with L. lactis pIL253, as determined by the Fisher’s exact test with the Yates correction.
1618 S. MANCINI ET AL.
Neither Coa nor vWbp are necessary for the
establishment of S. aureus IE when ClfA is present
In the light of the results obtained using the L. lactis
surrogate expression system, we further investigated the
ability of Coa and vWbp to colonize valve vegetations
in the S. aureus background, in the presence or absence
of ClfA. To this end, S. aureus Newman and isogenic
mutants devoid of coa, vWbp or/and clfA, individually
or in combination, were used. The defects in blood
clotting of these mutants have already been
described [16].
Rats were challenged with different inocula of S.
aureus Newman allowing quantification of infectivity
[6]. Valve infection was evaluated 24 h after challenge
as described above. As shown in Figure 5, deletion of
either the coa or vWbp gene did not significantly
decrease infectivity (83% and 64% infected vegetations,
respectively). In contrast, the absence of clfA (S. aureus
ΔclfA/coa/vWbp) led to a significant decrease in S.
aureus infectivity (45% infected vegetations; P = 0.03
compared to parent), in line with the results reported in
a previous work [6]. Moreover, inactivation of coa and
vWbp, in addition to that of clfA (S. aureus ΔclfA/Δcoa/
ΔvWbp), resulted in a slight but insignificant decrease
of S. aureus infectivity (36% infected vegetations) as
compared to that of the single clfA-defective mutant
(45% infected vegetations). Of note, the bacterial den-
sities in the vegetations of the animals that developed
endocarditis were not significantly different, ranging
from 7.24 to 8.89 log10 CFU/g. These results confirm
that ClfA is the major determinant in the establishment
Figure 3. Evolution of vegetation infection after challenge with
parent L. lactis pIL253 and recombinant L. lactis Coa or L. lactis
vWbp (a) and in vitro killing by platelets (b). (a) Groups of 6–10
rats were inoculated with of 107 CFU and sacrificed at various
times after challenge. Data represent mean ± SD of vegetation
bacterial titres. *, P < 0.01 vs L. lactis pIL253 and L. lactis vWbp;
# P < 0.01 vs L. lactis pIL253, as compared by the one-way
ANOVA followed by Tukey’s multiple comparisons test. (b)
Killing of L. lactis by platelets after 4 and 24 h of exposure. *,
P < 0.05 by one-way ANOVA followed by Tukey’s multiple
comparisons test.
Figure 4. vWbp does not increase L. lactis IE in the presence of
clfA. Experimental endocarditis induced by inoculation of parent
L. lactis pIL253 and recombinant L. lactis expressing clfA or
vWbp alone or in combination. Rats with catheter-induced
aortic vegetations were challenged with 104 or 105 CFU of the
indicated strains. The columns express the percentage of
infected vegetations 24 h after inoculation. The number of
infected/total number of vegetations per group is indicated at
the bottom of the columns. No significant differences (P > 0.05)
were observed when infection rates and bacterial burden in
vegetations were compared.
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S. aureus IE and suggest that its presence might out-
shine other virulence factors, such as vWbp in this
particular animal model.
Discussion
We here examined the role of the two S. aureus procoa-
gulant factors (Coa and vWbp) in the initiation of IE. This
study was based on the assumption that by triggering
fibrin formation and platelet aggregation, two essential
events in the vegetation development, Coa and vWbp
might contribute to the establishment of IE. To test this
hypothesis, we used the poorly pathogenic L. lactis as a
surrogate vector and investigated the effects of heterolo-
gous expression of the S. aureus procoagulant factors on
its ability to colonize heart valve vegetations, using a rat
model of catheter-induced experimental endocarditis.We
generated recombinant L. lactis strains and showed that
they could express and efficiently secrete the S. aureus
coagulases. Moreover, consistent with the work of
McDevitt and others, who showed that Coa was partly
retained on S. aureus surface [24], we observed that Coa,
but not vWbp, is partially retained on L. lactis cell wall.
Unexpectedly, the expression of the S. aureus coagu-
lases produced contrasting effects on the abilities of
recombinant lactococci to infect damaged valves. On the
one hand, we observed that Coa did not confer lactococci
an increased ability to induce IE in rats, as assessed 24 h
after challenge. These results are in agreement with pre-
vious studies showing that Coa is not involved in the
initiation of S. aureus IE [6,20,21]. However, at that time
the presence of vWbp was unknown and its presence
might have compensated for and thus outshined the loss
of Coa function. Remarkably, we also found that Coa not
only failed to promote IE, but even made lactococci less
infective. In fact, following the evolution of IE over 24 h
we observed three profiles for the parent and the vWbp
and coa recombinants. While vegetation densities of the
parent remained stable, those of the vWbp recombinant
increased whereas those of the coa recombinant decreased
down to infection eradication. Yet, this effect was not due
to reduced capability of Coa-positive lactococci to colo-
nize the valves, as titers comparable to those of the parent
lactococci and L. lactis vWbp were found in the vegeta-
tions 2 h after challenge.
Although a precise mechanism of L. lactis Coa clear-
ing remains to be determined, one plausible hypothesis
is that Coa could induce a progressive killing of lacto-
cocci by platelets present in the vegetations. Consistent
to this notion, it was previously shown that platelets
can release microbicidal proteins that kill bacteria
within vegetations [25–27]. Moreover, it was also
demonstrated that, during the early phase of infection,
the induction of the coagulation cascade by bacteria
leads to their entrapment and killing within the clot,
likely by the generation of additional host antimicrobial
peptides [28,29]. We observed that the ability of L.
lactis Coa cells to coagulate plasma was much faster
than that of L. lactis vWbp cells, requiring 100-times
less bacteria to induce clot formation after 24 h (sup-
plementary Figure S1). This, together with the fact that
L. lactis Coa displayed a greater ability to aggregate
platelets and to coagulate plasma than L. lactis vWbp
supports the killing hypothesis of the L. lactis Coa
strain in the platelet-fibrin vegetation meshwork.
The detrimental effects of Coa expression in the early
steps of IE may explain the need for tight regulation in S.
aureus. In this organism, coagulase is only transiently
produced at the beginning of the exponential growth
phase [30], a limited period of time that could be enough
to promote fibrinogen-fibrin binding while avoiding
overwhelming activation of platelets. This would be con-
sistent with the observation by Panizzi et al [22], who
showed that Coa production was restricted to the
Figure 5. Neither coa nor vWbp significantly affects S. aureus
Newman infectivity. Experimental endocarditis induced by
inoculation of parent S. aureus Newman and isogenic mutant
strains lacking coa, vwbp or clfA alone or in combination. Rats
with catheter-induced aortic vegetations were challenged with
104 CFU of the indicated S. aureus Newman strains. The col-
umns express the percentage of infected vegetations 24 h after
bacterial challenge. The number of infected/total number of
vegetations per group is indicated at the bottom of the col-
umns. Statistical comparisons were determined by the Chi-
square test. NS, not significant.
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growing edge of mature vegetations at the interface with
the blood stream in mice infected with S. aureus
Newman, where bacteria are not yet clustered in station-
ary phase-like, or biofilm-like, conditions.
On the other hand, the present results show for the
first time that the expression of vWbp in L. lactis might
contribute to the establishment of IE. Recently, S. aur-
eus and Staphylococcus lugdunensis were shown to bind
directly to the blood glycoprotein von Willebrand fac-
tor (VWF) [31,32]. In case of S. aureus, binding to
VWF is mediated by secreted vWbp, which in turn
binds to S. aureus via cell-wall anchored ClfA [31,32].
Thus, VWF present in the vegetations may act as local
ligand to trap circulating bacteria.
However, this scenario was unlikely in vWbp-produ-
cing lactococci, because recombinant vWbp was
secreted and not attached to the bacterial surface.
Therefore, the increased infectivity of these recombi-
nants was more likely due to the vWbp procoagulant
activity alone, via binding to VWF present in vegeta-
tions and entrapping the organisms within the valve
lesions [33,34]. Moreover, the fact that vWbp lactococci
were less pro-coagulant than their Coa-producing
counter parts, plus the fact that vWbp was not attached
to the bacterial wall, might explain a lower platelet
proximity and a lower platelet-induced lethality.
In this study we also tested the role of ClfA in these
constructs. ClfA binds to fibrinogen-fibrin and also pro-
motes platelet activation. This is why it increases infectiv-
ity when produced in lactococci [4,7]. However ClfA also
binds vWbp and bridges lactococci to VWF, as in S.
aureus [31]. We asked whether this process would affect
infectivity of either cflA or vWbp lactococcal recombi-
nants, or S. aureus deleted in various vWbp, coa or clfA
gene combinations. Using S. aureus Newman, a strain
that does not express a functional FnbpA [35], we found
that ClfA was the major determinant of infectivity, and
that vWbp or Coa did not add any advantage in this
particular model of IE. Thus, while vWbp had indeed
some effect in promoting infectivity in lactococcal recom-
binants, it became dispensable in the presence of ClfA.
In sum, vWbp appears to play a marginal role in the
initiation of S. aureus IE. However, while this assump-
tion is true for the present IE experimental model,
where pre-existing physical valve damage is the nidus
of infection, it might be different in other scenarios,
such as minimal endothelial lesions, which are asso-
ciated with the presence of high VWF levels. In that
case the role of vWbp, together with ClfA to bridge the
bacterium to the inflamed endothelium, might become
more prominent. Whether vWbp becomes the predo-
minant player of S. aureus infection in such circum-
stances needs yet to be clarified in vivo.
Materials and methods
Bacterial strains and growth conditions
The bacterial strains used in this study are listed in
Table 1. L. lactis were cultivated at 30°C in M17 broth
(Becton Dickinson, Sparks, MD) or on M17 agar plates
supplemented with 0.5% glucose. S. aureus were grown
under static condition in tryptic soy broth or on tryptic
soy agar (Becton Dickinson). Escherichia coli were
grown at 37°C in Luria-Bertani medium (Becton
Dickinson). When required, antibiotics were added to
the media at the following concentrations: erythromy-
cin 5 µg/ml for L. lactis and 500 µg/ml for E. coli,
chloramphenicol 10 µg/ml for L. lactis and 30 µg/ml
for E. coli and ampicillin 100 µg/ml for E. coli.
Plasmids and plasmid constructions
All the plasmids and primers used in this work are
listed in supplementary Table S1. S. aureus genomic
DNA was extracted as previously described [36]. S.
aureus Newman coa and vWbp were PCR amplified
using the forward primers coa-fw and vWbp-fw and
the reverse primers coa-rv and vWbp-rv. The resulting
PCR products were digested with SalI and PstI and
ligated into the pori23 vector, also digested with the
same enzymes. The resulting constructs pori23-coa and
pori23-vWbp containing coa and vWbp under the con-
trol of the lactococcal P23 constitutive promoter [37]
were amplified in the E. coli DH5α intermediate host
and purified using the Wizard® Plus SV Minipreps
Table 1. Bacterial strains used in this study.
Strain a Properties
Source or
Reference
L. lactis subsp.
cremoris 1363
Wild type [4]
L. lactis pIL253 Parent strain carrying the empty
vector pIL253
[4]
L. lactis Coa Derivative of pIL253 expressing S.
aureus coa
This study
L. lactis vWbp Derivative of pIL253 expressing S.
aureus vWbp
This study
L. lactis Coa/vWbp Derivative of pIL253 expressing S.
aureus coa and vWbp
This study
L. lactis ClfA Derivative of pIL253 expressing S.
aureus clfA
[4]
L. lactis ClfA/vWbp Derivative of pIL253 expressing S.
aureus clfA and vWbp
This study
S. aureus Newman Wild type [16]
S. aureus Δcoa Derivative of Newman lacking coa [6]
S. aureus ΔvWbp Derivative of Newman lacking vwbp [16]
S. aureus ΔclfA Derivative of Newman lacking clfA [16]
S. aureus Δcoa/
ΔvWbp
Derivative of Newman lacking coa
and vWbp
[16]
S. aureus Δcoa/
ΔvWbp/ΔclfA
Derivative of Newman lacking coa,
vWbp and clfA
[16]
E. coli DH5α Promega
a Coa: staphylocoagulase; vWbp: von Willebrand factor-binding protein;
ClfA: clumping factor A
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DNA Purification System (Promega, Madison, WI).
The absence of mutations in the inserts was verified
by commercial sequencing. The constructs were finally
electroporated into L. lactis subsp. cremoris MG1363
cells using a protocol described previously [38].
Characterization of the recombinant L. lactis
strains
The functionality of recombinant L. lactis Coa and L. lactis
vWbp was verified by assessing blood coagulation. Briefly,
100 μl containing 107 CFU of L. lactis cells were added to
900 μl of citrated rat blood in polystyrene tubes. The tubes
were incubated at 37°C for 24 h and blood coagulation was
verified by tipping the tubes at a 45° angle [16]. For the clot
inhibition tests, the direct thrombin inhibitor dabigatran
(150 ng/ml, final concentration) [39] was added to citrated
rat blood prior to addition of the bacteria.
Quantification of platelet aggregation
The ability of L. lactis cells and cell-free supernatants to
induce platelet aggregation in vitro by means of secreted
and surface-associated coagulases was measured by light
transmission aggregometry. Platelet-rich plasma (PRP)
and platelet-poor plasma (PPP) were prepared as pre-
viously described [40]. Twenty microliters containing
either L. lactis cells (107 CFU) or cell-free supernatants
of the same cultures were added to 180 μl of PRP in
siliconized flat-bottom cuvettes. The light transmission
of PRP without added bacteria and the light transmission
of PPP were defined as 0% and 100% light transmission,
respectively. Platelets were also tested with 10 μM ADP,
used as positive control. Aggregation was recorded for
20 min. Three independent assays were performed.
Titration of plasma clotting activity of L. lactis
To titrate the plasma clotting activity over time, 100 μl of
different inoculum sizes (from 105 to 108 CFU) of L. lactis
cells (serially diluted in PBS) weremixed with 100 μl of rat
plasma in polystyrene tubes. After gently mixing, the
tubes were incubated at 37°C and observed at different
times (4, 8, 12, 24 and 36 h) until clot formation.
Ethics statement
Animal experiments were carried out in accordance
with the recommendations of the Swiss Federal Act
on Animal Protection. All animal protocols were
reviewed and approved by the Cantonal Committee
on Animal Experiments of the State of Vaud (Permit
Number: 879.9).
Animal model of endocarditis
Catheter-induced sterile aortic vegetations were produced
in female Wistar rats (180–200 g) as previously described
[41]. Twenty-four hours after catheterization, animals
were inoculated intravenously (i.v.) with increasing num-
bers of either L. lactis (ranging from 104 to 108 CFU/ml) or
S. aureus (104 CFU/ml). The catheter was left in place
throughout the entire experiment. The cardiac vegetations
were sterilely removed, weighed, homogenized and plated
on M17 agar plates containing the appropriate antibiotic
marker. Vegetation infection was evaluated 24 h later [6,7]
and expressed as log10 CFU/g of vegetation. Aortic valve
vegetations were considered positive when they contained
> 2 log10 CFU/g, which corresponds to the lower limit of
detection of growth. In certain experiments, designed to
measure diseases progression, rats were sacrificed at dif-
ferent time points after i.v. challenge with high inoculum
sizes (107 CFU of L. lactis). Bacterial densities in the
vegetations were measured as above.
In vitro killing of L. lactis by platelets
PRP were prepared from anticoagulated rat blood as
described above. L. lactis suspensions containing 105–
106 CFU/ml were mixed with PRP at a 1:1 ratio in
polypropylene tubes. To monitor killing activity of pla-
telets, viable bacterial cells were enumerated after 4 and
24 h incubation at 37°C. In order to accurately count
viable bacteria, samples were vortexed and mixed by
pipetting up and down before plating to disrupt any
visible aggregate. Experiments were performed in tri-
plicate in two independent occasions.
Statistical analysis
The incidences of valve infection were compared by the
Fisher’s exact test or the Chi-squared test. Bacteria CFUs
were compared by the one-way ANOVA followed by
Tukey’s multiple comparisons test. A value of P < 0.05
was considered significant by using two-tailed signifi-
cance levels. All statistical analyses were performed with
the GraphPad Prism 6.0 program (www.graphpad.com).
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